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The nuclear factor-kB (NF-kB) transcription factors control many physiological processes including
inﬂammation, apoptosis, and angiogenesis. In our search for NF-kB inhibitors from natural resources, we
identiﬁed 40 ,6-dihydroxy-4-methoxyisoaurone (ISOA) as an inhibitor of NF-kB activation from the seeds
of Trichosanthes kirilowii. However, the mechanism by which ISOA inhibits NF-kB activation is not fully
understood. In the present study, we demonstrated the effect of ISOA on NF-kB activation in TNF-a-
stimulated HeLa cells. This compound suppressed NF-kB activation through the inhibition of IkB kinase
(IKK) activation. ISOA also has an inﬂuence on upstream signaling of IKK through the inhibition of
expression of adaptor proteins, TNF receptor-associated factor 2 (TRAF2) and receptor interacting protein
1 (RIP1). Consequently, ISOA blocked the phosphorylation and degradation of the inhibitor of NF-kB
alpha (IkBa), and subsequent phosphorylation and nuclear translocation of p65. The suppression of NF-
kB activation by ISOA led to the down-regulation of target genes involved in inﬂammation, proliferation,
as well as potentiation of TNF-a-induced apoptosis. Taken together, this study extends our understanding
on the mechanisms underlying the anti-inﬂammatory and anti-cancer activities of ISOA. Our ﬁndings
provide new insight into the molecular mechanisms and a potential application of ISOA for inﬂammatory
diseases as well as certain cancers.
© 2015 The Authors. Production and hosting by Elsevier B.V. on behalf of Japanese Pharmacological
Society. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/
licenses/by-nc-nd/4.0/).1. Introduction
Nuclear factor kB (NF-kB) is a crucial pleiotropic transcription
factor which regulates inﬂammation, the innate and adaptive im-
mune response, apoptosis, and tumor invasion (1e3). Fivemembers40 ,6-dihydroxy-4-methoxyi-
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d/4.0/).of this transcription factor family have been identiﬁed: RelA (p65),
RelB, c-Rel, NF-kB1 (p105/p50) and NF-kB2 (p100/p52) (2). All
members of the NF-kB family harbor an N-terminal Rel homology
domain (RHD), which interacts with DNA elements and mediates
homo- and hetero-dimerization. The complex p50/p65 is the most
abundant form of heterodimer of the NF-kB family and it keeps in an
inactive state in the cytoplasm bound to proteins of the IkB family,
which are inhibitors of NF-kB (4). NF-kB is activated by a sequence
involving the phosphorylation, ubiquitination, and degradation of
IkBa, and the phosphorylation of p65, which in turn lead to the
translocation of NF-kB to the nucleus, where it binds to speciﬁc
response elements in the DNA (5). The phosphorylation of IkBa is
catalyzed by IkB kinase (IKK), which is essential for NF-kB activation
bymost stimuli. Several lines of evidence also support a role for TNF
receptor-associated factor 2 (TRAF2) and receptor interacting pro-
tein 1 (RIP1) in TNF signaling leading to NF-kB activation (6).
It is reported that NF-kB regulates more than 150 genes,
including those involved in immunity and inﬂammation, anti-
apoptosis, cell proliferation, tumorigenesis, and the negativenese Pharmacological Society. This is an open access article under the CC BY-NC-ND
Fig. 1. Effect of ISOA on the TNF-a-induced NF-kB-dependent reporter gene
expression. (A) Structure of 40 ,6-dihydroxy-4-methoxyisoaurone (ISOA). (B) HeLa cells
were transiently transfected with a NF-kB-dependent reporter gene for 48 h and then
pretreated for 12 h with the indicated concentrations of ISOA followed by stimulation
for 12 h with 10 ng/ml TNF-a, and the luciferase activity was determined as described
in “Materials and methods”. Data represented as mean ± standard deviation of three
independent experiments. **P < 0.01, ***P < 0.001, signiﬁcantly different when
compared with TNF-a-stimulated normal cells. (C) HeLa cells were treated with the
indicated concentrations of ISOA. After 24 h incubation, cell viability was determined
by MTT assays. Data represented as mean ± standard deviation of three independent
experiments.
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of various inﬂammatory cytokines, including interleukin 8 (IL-8),
tumor necrosis factor alpha (TNF-a), and monocyte chemotactic
protein 1 (MCP1) as well as genes encoding inducible nitric oxide
synthase (iNOS), immunoreceptors, cell adhesion molecules, he-
matopoietic growth factors, and growth factor receptors (8e10). In
addition to regulating the transcription of genes important for
immune and inﬂammatory responses, NF-kB also controls the
expression of genes that are critical in the early and late stages of
aggressive cancers, including antiapoptotic proteins cellular in-
hibitor of apoptosis 1 (cIAP1), cIAP2, TNF receptor-associated factor
1 (TRAF1), B-cell lymphoma 2 (Bcl2), cellular FLICE inhibitory
protein (FLIP); gene required for proliferation such as cyclooxy-
genase-2 (COX-2); and genes required for invasion and angiogen-
esis such as inter-cellular adhesion molecule 1 (ICAM-1) and
vascular endothelial growth factor (VEGF) (11, 12).
40,6-Dihydroxy-4-methoxyisoaurone (ISOA) is a natural product
isolated from the Trichosanthes kirilowii seeds, ISOA showed potent
anticancer activity through inhibition of hypoxia-inducible factor-
1a (13). ISOA also was a potent inhibitor of nuclear factor kB (NF-kB)
activation; however, the molecular mechanism has not been suf-
ﬁciently explained (14). In present study, we investigated the ef-
fects of ISOA on the NF-kB activation pathway and on the
expression of NF-kB target genes induced by TNF-a. We here
describe molecular mechanism by which ISOA inhibits NF-kB
activation, which in turn down-regulates the expression of target
genes involved in inﬂammation (IL-8, TNF-a, and MCP1), cell sur-
vival (cIAP1, cIAP2, TRAF1, and FLIP), proliferation (COX-2), invasion
(ICAM-1), and angiogenesis (VEGF), and potentiates TNF-a-induced
apoptosis signiﬁcantly via activation of caspase-8. Our ﬁnding may
expand the application of ISOA to a valuable candidate for the
intervention of NF-kB-dependent pathological conditions such as
inﬂammation and cancer.
2. Materials and methods
2.1. Cell culture and reagents
HeLa cells were grown in DMEM with penicillin (100 U/ml)-
streptomycin (100 U/ml) (Invitrogen, Carlsbad, CA, USA) and 10%
heat-inactivated fetal bovine serum (Hyclone, Logan, UT, USA) at
37 C with 5% CO2 atmosphere in a humidiﬁed incubator. HeLa cells
were purchased from American Type Culture Collection (ATCC,
Manassas, VA, USA). TNF-a was obtained from R&D Systems
(Minneapolis, MN, USA). ISOA was isolated from T. kirilowii seeds
and its structure is shown in Fig. 1A. The purity of ISOA was more
than 98% in high-performance liquid chromatography analysis.
2.2. Transfections and luciferase reporter assay
A pNF-kB-Luc plasmid for NF-kB luciferase reporter assay was
obtained from Strategene (La Jolla, CA, USA). Transfections were
performed as described previously (17). NF-kB-dependent lucif-
erase activity was measured using the Dual Luciferase Reporter
Assay system. Brieﬂy, HeLa cells (1  105 cells/well) were seeded in
awell of 96-well plate for 24 h. The cells were then transfected with
plasmids for each well and then incubated for a transfection period
of 24 h. After that, the cell culture medium was removed and
replaced with fresh medium containing various concentrations of
ISOA for 12 h, followed by treatment with 10 ng/ml of TNF-a for
12 h. Luciferase activity was determined in Luminoskan™ Ascent
Microplate Luminometer (Thermo Scientiﬁc, Waltham, MA, USA)
by injecting 100 ml of assay buffer containing luciferin and
measuring light emission for 10 s. Co-transfection with pRL-CMV
(Promega, Madison, WI, USA), which expresses Renilla luciferase,was performed to enable normalization of data for transfection
efﬁciency.2.3. Measurement of cell viability by MTT assay
HeLa cells were seeded at 1  105 cells/ml in a well of 96-well
plate containing 100 ml of DMEM medium with 10% FBS and
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were pretreated with different concentrations of ISOA (0.3e10 mM)
for 24 h. At the end of the experiment, the media was removed and
cells were cultured with MTT solution (5 mg/ml) [3-(4,5-
dimethylthiazol-2-yl)-2,5- diphenyltetrazolium bromide] (Sigma,
St. Louis, MO, USA) for 4 h. The viable cells converted MTT to for-
mazan, which generated a blue purple color after dissolving in
100 ml of DMSO. The absorbance at 570 nm was measured by
Multiskan GO.
2.4. Western blot analysis
HeLa cells were cultured in 10 cm-dishes and allowed to adhere
for 24 h. The culture mediumwas removed and replaced with fresh
medium containing ISOA at indicated concentrations for 12 h and
then treatment with 10 ng/ml of TNF-a for indicated times. Whole-
cell extracts were obtained by lysing cells in ice-cold lysis buffer
(50 mM TriseHCl, pH 7.5, 1% Nonidet P-40, 1 mM EDTA, 1 mM
phenylmethylsulfonylﬂuoride) supplemented with the protease
inhibitor cocktail (BD Biosciences, San Diego, CA, USA). In certain
experiments, the nuclear extracts were prepared using NE-PER
nuclear and cytoplasmic extraction reagent. An aliquot of protein
extracts were used to determine protein concentration by the
Bradfordmethod. Fifty microgram of whole-cell extracts or 30 mg of
nuclear extract protein per lane was separated by SDS-
polyacrylamide gels and followed by transferring to a poly-
vinylidenediﬂuoride membrane (Millipore, Bedford, MA, USA). The
membrane was blocked with 5% skim milk, and then incubated
with the corresponding antibody. Antibodies for IkBa, phosphor
(Ser32)-speciﬁc IkBa, p65, phosphor (Ser536)-p65, PARP and
caspase-8 were purchased from Cell Signaling Technology (Beverly,
MA, USA). Antibodies for phosphor (Ser176)-IKKa/b, cIAP1, cIAP2,
TRAF1, TRAF2, Bcl2, FLIP, COX-2, VEGF, ICAM-1, RIP1 and Topo-I
were obtained from Santa Cruz Biotechnology (Santa Cruz, CA,
USA). Antibody for a-tubulin was obtained from Sigma (St. Louis,
MO, USA). Membranes were then incubated with appropriate sec-
ondary antibody coupled to horseradish peroxidase and visualized
by enhanced chemiluminescence according to the manufacturer's
instructions (Amersham Pharmacia Biotec, Buckinghamshire, UK).
2.5. Immunoﬂuorescence assay
HeLa cells were seeded into 24-well plates at 1  104 cells/well.
24 h later, cells were pretreated with ISOA (10 mM) for 12 h, fol-
lowed by treatment with 10 ng/ml TNF-a for 30 min. Cells pre-
treated with DMSO and 10 ng/ml TNF-a alone were used as
negative and positive controls, respectively. After treatment, cells
were rinsed once in PBS, ﬁxed in fresh 4% paraformaldehyde for
30min at room temperature, and permeabilizedwith 0.2% Triton X-
100. Cells were blocked with 5% BSA in PBS for 30 min and incu-
bated overnight with the primary NF-kB p65 antibody at 4 C, fol-
lowed by incubation with Alexa Flour® 488 goat anti-rabbit lgG
(H þ L) for 30 min at room temperature, then with DAPI for 30 min
before observation. The p65 protein appeared green under ﬂuo-
rescence microscopy and the nuclei appeared blue. The green and
blue images were merged using Image J software to produce cyan
ﬂuorescence in areas of co-localization.
2.6. RT-PCR analysis
Reverse transcription-PCR (RT-PCR) was performed to deter-
mine NF-kB target gene expression as previously described (15). In
brief, HeLa cells were preincubated with the indicated concentra-
tions of ISOA at 37 C for 12 h and then followed by treatment with
10 ng/ml of TNF-a for 12 h. Cells were harvested and washed twicewith ice-cold PBS, and then total RNA was isolated from cells using
RNeasy Mini kits according to the manufacturer's instructions
(Qiagen, CA, USA). Complementary DNAwas synthesized from 1 mg
of total RNA in a 20 ml reverse transcription reaction mixture ac-
cording to the manufacturer's protocol (TaKaRa Bio, Kyoto, Japan).
The following primer pairs were used for RT-PCR ampliﬁcation:
human interleukin-8 (IL-8), 50-TCTGCAGCTCTGTGTGAAGG-30 and
50-ACTTCTCCACAACCCTCTG-30; human MCP1, 50-CCCCAGTCACCT-
GCTGTTAT-30 and 50-AGATCTCCTTGGCCACAATG-30; human TNF-a,
50-CTGCCCCAATCCCTTTATT-30 and 50-CCCAATTCTCTTTTTGAGCC-
30; GAPDH, 50-ACCACAGTCCATGCCATCAC-30 and 50-TCCACCACCCT-
GTTGCTGTA-30. GAPDHwas used as the housekeeping gene control.
PCR products were run on 3% agarose gel and then stained with
ethidium bromide. Stained bands were visualized under UV light
and photographed.
2.7. Apoptosis assays
Annexin V-staining was performed using Annexin V-FITC
apoptosis detection kit (BD Biosciences, CA, USA) following the
instructions of the manufacturer. Brieﬂy, after incubation, cells
were harvested, washed with PBS (pH 7.4), centrifuged, and stained
with Annexin V-FITC and 2 mg/ml propidium iodide (PI) in binding
buffer (10 mM Hepes, pH 7.4, 140 mM NaCl, 2.5 mM CaCl2) for
15 min at 37 C in the dark. The samples were analyzed by ﬂow
cytometry using a FACScan ﬂow cytometer. The CellQuest software
was used to analyze the data (BectoneDickinson).
2.8. Statistical analysis
All values are expressed as mean ± S.D. A comparison of the
results was performed with one-way ANOVA and Tukey's multiple
comparison tests (Graphpad Software, Inc, San Diego, CA, USA).
Statistically signiﬁcant differences between groups were deﬁned as
P-values less than 0.05.
3. Results
3.1. ISOA inhibits TNF-a-induced NF-kB-dependent reporter gene
expression
In an effort to identify NF-kB inhibitors from natural resources,
we have identiﬁed ISOA from T. kirilowii seeds (Fig. 1A). To inves-
tigate the effect of ISOA on the induced NF-kB activation by TNF-a,
we performed NF-kB reporter assay. After cells were transiently
transfected with the NF-kB-regulated luciferase reporter vector, the
cells were further incubated with TNF-a in the presence of various
concentrations of ISOA. We found that TNF-a-induced NF-kB re-
porter activity was substantially suppressed by ISOA in a dose-
dependent manner (Fig. 1B). To evaluate the effect of ISOA on cell
viability of HeLa cells, MTT assay was performed. ISOA did not
display signiﬁcant cellular toxicity on HeLa cells up to 10 mM
(Fig. 1C).
3.2. ISOA inhibits TNF-a-induced phosphorylation and nuclear
translocation of p65
Since the phosphorylation and nuclear translocation of p65 is a
critical step for NF-kB transcriptional activity (16), we examined
whether ISOA affects TNF-a-induced phosphorylation of p65 at
Ser536. Either phosphorylated form of p65 or p65 was reduced in
the nuclear fraction in the presence of ISOA, while TNF-a alone did
induce the phosphorylation and translocation of p65 (Fig. 2A). The
p65 were increased in the cytoplasmic fraction in the presence of
ISOA.Whereas ISOA blocked TNF-a-induced phosphorylation of the
Fig. 2. Effect of ISOA on the TNF-a-induced phosphorylation and nuclear translocation of p65. (A) HeLa cells were preincubated with indicated concentrations of ISOA for 12 h
and then treated with 10 ng/ml TNF-a for 30 min. Nuclear extracts were analyzed by Western blot using indicated antibodies for p-p65, p65 and Topo-I. (B) HeLa cells were
incubated with 10 mM ISOA for 12 h and then incubated with 10 ng/ml TNF-a for 30 min. Cytoplasmic extracts were analyzed by Western blot using indicated antibodies for p-p65,
p65, and tubulin. Data represented as mean ± standard deviation of three independent experiments. *P < 0.05, **P < 0.01, ***P < 0.001, signiﬁcantly different when compared with
TNF-a-stimulated normal cells. (C) HeLa cells were incubated with 10 mM ISOA for 12 h and followed by 10 ng/ml TNF-a stimulation for 30 min. After ﬁxation, cells were stained
with speciﬁc anti-p65 antibody followed Alexa Flour® 488 (green), and the nucleus was counterstained with DAPI (blue) and examined by Fluorescence microscopy. Scale bars:
20 mm. Images were acquired for each ﬂuorescence channel, using suitable ﬁlters with 40 objective. The green and blue images were merged using J software.
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immunoﬂuorescence to observe p65 translocation in HeLa cells.
The results indicated that in untreated, as well as ISOA (10 mM)
pretreated followed by TNF-a treated cells, p65 was localized in the
cytoplasm, whereas in cells treated with TNF-a alone, p65 was
translocated to the nucleus (Fig. 2C).
3.3. ISOA inhibits TNF-a-induced phosphorylation and degradation
of IkBa via suppression of IKKa/b activation, and the expression of
adaptor protein of TNF receptor (TNFR) 1 signaling
The translocation of NF-kB to the nucleus is preceded by the
phosphorylation, ubiquitination, and proteolytic degradation ofIkBa (17). To determine whether inhibition of TNF-a-induced NF-kB
activation by ISOA is caused by inhibition of IkBa degradation, we
exposed the HeLa cells to ISOA for 12 h and then treated themwith
TNF-a for 30 min. We then prepared cytoplasmic extracts and
analyzed phosphorylation and degradation of IkBa byWestern blot.
ISOA potently inhibited the TNF-a induced phosphorylation and
degradation of IkBa in a dose-dependent manner (Fig. 3A). Since
IKK complex acts as a convergence point for a variety of activating
signals for NF-kB and plays a critical role in degradation of IkB
proteins, we investigated whether ISOA inhibits the TNF-a-induced
phosphorylation of IKKa/b. As shown in Fig. 3B, ISOA suppressed
TNF-a-induced phosphorylation of IKKa/b dose-dependently. In
TNF-a-induced NF-kB activation, binding of TNF-a to TNFR1
Fig. 3. Effect of ISOA on TNF-a-induced phosphorylation and degradation of IkBa, phosphorylation of IKKa/b and expressions of adaptor proteins of TNF receptor (TNFR) 1
signaling. (A) HeLa cells were preincubated with indicated concentrations of ISOA for 12 h and then treated with 10 ng/ml TNF-a for 30 min. Cytoplasmic extracts were analyzed by
Western blot using indicated antibodies for p-IkBa, IkBa, and tubulin. (B) HeLa cells were incubated with 10 mM ISOA for 12 h and then incubated with 10 ng/ml TNF-a for 30 min.
Cytoplasmic extracts were analyzed byWestern blot using indicated antibodies for p-IKKa/b and tubulin. (C) HeLa cells were incubated with 10 mM ISOA for 12 h and then incubated
with 10 ng/ml TNF-a for 30 min. Cytoplasmic extracts were analyzed by Western blot using indicated antibodies for TRAF2, RIP1 and tubulin. Data represented as mean ± standard
deviation of three independent experiments. *P < 0.05, **P < 0.01, ***P < 0.001, signiﬁcantly different when compared with TNF-a-stimulated normal cells.
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stream signaling proteins to their cytoplasmic domains (18).
Among them TRAF2 and RIP1 are known to be critical in the TNFR1
signaling leading to NF-kB activation (6). For this reason, we
investigated whether ISOA affects the adaptor protein expression of
TNFR1 signaling pathway. As shown in Fig. 3C, ISOA suppressed the
expressions of TRAF2 and RIP1 dose-dependently.
3.4. ISOA inhibits the expressions of TNF-a-induced NF-kB-
regulated gene products
Because NF-kB regulates major inﬂammatory cytokines and
chemokines, including TNF-a, IL-8 and MCP1, many of which are
potent activators for NF-kB (8, 12, 19), we examined whether ISOA
can modulate the expression of these gene products induced by
TNF-a. TNF-a signiﬁcantly induced expression of TNF-a, IL-8, and
MCP1 mRNA levels, however, the induced-expression was blocked
by ISOA in a dose-dependent manner (Fig. 4A). ISOA downregulated
the TNF-a-induced mRNA expressions of TNF-a, IL-8, and MCP1 to
almost basal levels at the concentration of 10 mM. To investigatewhether ISOA inhibits the induced expressions of NF-kB targets
genes involved in early and late stages of aggressive cancers and
inﬂammation, we analyzed TNF-a-induced expressions of cIAP1,
cIAP2, TRAF1, Bcl2, FLIP, COX-2, ICAM-1 and VEGF. After HeLa cells
were stimulated with 10 ng/ml TNF-a for 12 h in the presence or
absence of ISOA, the induced expressions of antiapoptotic proteins
such as cIAP1, cIAP2, TRAF1, Bcl2 and FLIP, protein involved in cell
proliferation COX-2, and proteins involved in tumor angiogenesis,
invasion and metastasis ICAM-1 and VEGF were analyzed by
Western blot. ISOA markedly suppressed TNF-a-induced expres-
sions of all these proteins in a dose-dependent manner (Fig. 4B).
3.5. ISOA potentiates TNF-a-induced apoptosis
HeLa cells were sequentially treated with ISOA and TNF-a, and
then stained with Annexin V-FITC and PI to analyze the effect of
ISOA on TNF-a-induced apoptosis in a ﬂow cytometer. As shown in
Fig. 5A, treatment of HeLa cells with vehicle only, TNF-a alone, and
ISOA alone induced apoptosis to 4.2%, 7.1%, and 20.6% respectively.
However, combined treatment of the cells with TNF-a and ISOA
Fig. 4. Effect of ISOA on TNF-a-induced NF-kB-regulated gene products. (A) HeLa cells were preincubated with indicated concentrations of ISOA for 12 h and then treated with
10 ng/ml TNF-a for an additional 12 h. RNA was isolated from cells, reverse-transcribed, and analyzed by RT-PCR for TNF-a, IL-8, and MCP1. GAPDH was used to show equal loading
of total RNA. (B) HeLa cells were incubated with 10 mM ISOA for 12 h and then incubated with 10 ng/ml TNF-a for an additional 12 h. Whole cell extracts were analyzed by Western
blot using indicated antibodies for cIAP1, cIAP2, TRAF1, Bcl2, FLIP, COX-2, ICAM-1, VEGF and tubulin. Data represented as mean ± standard deviation of three independent ex-
periments. *P < 0.05, **P < 0.01, ***P < 0.001, signiﬁcantly different when compared with TNF-a-stimulated normal cells.
J. Ma et al. / Journal of Pharmacological Sciences 130 (2016) 43e5048resulted in a signiﬁcant increased the Annexin V-positive cell
population (47.3%). Since caspases are a group of cysteine proteases
critical for apoptosis of eukaryotic cells (20), we investigated
whether ISOA affects TNF-a induced activation of caspase-8. TNF-a
alone slightly and ISOA alone signiﬁcantly affected the activation of
caspase-8, whereas cotreatment with TNF-a and ISOA potentiated
their activation, as indicated by the presence of cleaved caspase-8
(Fig. 5B, top panel). We also used the PARP cleavage assay to
detect TNF-a-induced apoptosis. Again, ISOA potentiated the effect
of TNF-a-induced PARP cleavage, although ISOA alone also induced
PARP cleavage (Fig. 5B, middle panel). These results showed that
ISOA enhances the apoptotic effects of TNF-a.
4. Discussion
Plants of T. kirilowii has been used for a long time in oriental
traditional medicine. The seed, fruit peel, and root of the plant are
widely used for treatment of cough, inﬂammation, diabetes, and
obstipation. ISOA is a compound derived from the seeds ofT. kirilowii, despite its various pharmacological activities, the mo-
lecular mechanism of anti-inﬂammatory effect of ISOA has not been
sufﬁciently explained. In this study, we identiﬁed ISOA as a potent
inhibitor of TNF-a-induced NF-kB activation and investigated
further how this compound suppressed NF-kB activation.
NF-kB is normally retained in the cytoplasm through interaction
with its inhibitor IkB. IkB exerts its inhibitory effects by associating
with the Rel homology domain of NF-kB proteins, effectively
masking their nuclear localization signals (21e24). Thus, it was
suggested that degradation of IkB by the proteasome is an essential
early step in the NF-kB activation pathway. In the present study, we
demonstrated that ISOA suppressed not only the expression of RIP1
and TRAF2, the adaptor proteins of TNF receptor but also the TNF-a-
induced phosphorylation of IKKa/b. This, in turn, inhibits the
phosphorylation and degradation of IkBa which is required for NF-
kB dimerization and maximal activation of transcription. The key
regulatory step in the IkBa degradation involves the activation of
IKK complex. Activation of IKK is mediated by phosphorylation
through various upstream kinases including transforming growth
Fig. 5. Effect of ISOA on the TNF-a-induced apoptosis. (A) HeLa cells were pretreated
with 10 mM ISOA for 12 h and then incubated with 10 ng/ml TNF-a for 24 h, and
subsequently stained with Annexin V-FITC and PI, followed by analysis using a ﬂow
cytometer. Representative plots of one set of triplicate experiments. Early apoptotic cell
(Annexin-Vþ and PI) were displayed in the lower right quadrant and late apoptotic
cells (Annexin-Vþ and PIþ) were shown in the upper right quadrant. (B) HeLa cells
were pretreated with 10 mM ISOA for 12 h and then incubated with 10 ng/ml TNF-a for
24 h. Whole cell extracts were analyzed by Western blot using indicated antibodies for
cleaved capase-8, cleaved PARP, and tubulin. Data represented as mean ± standard
deviation of three independent experiments. ***P < 0.001, signiﬁcantly different when
compared with TNF-a-stimulated normal cells.
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Akt or other kinases (25). It is well known that the TNFR1 interacts
with the signaling protein TNFR1-associated death domain protein
(TRADD), which recruits the adaptor proteins, TRAF2, RIP1 and Fas-
associated protein with death domain (FADD) (6, 26, 27). Subse-
quently, TRAF2 and RIP1 are polyubiquitinated and induce the
recruitment of upstream kinase such as TAK1 to activate IKK
complex (28). Therefore, our results suggest that the suppression of
TRAF2 and RIP1 by ISOA could, at least in part, be responsible forthe inhibition of upstream kinase in the activation of IKK complex,
thereby repressing NF-kB signaling.
Increasing evidences suggested that NF-kB pathway plays a
crucial role in a link between inﬂammation and cancer, and
demonstrated an essential role for NF-kB in various cancers and
inﬂammatory diseases (11, 29). Studies have shown that anti-
apoptotic activity of NF-kB involves the inhibition of TNF-a-
induced apoptosis through induction of a variety of anti-apoptotic
proteins (4, 30). Our results also showed that ISOA inhibits the
TNF-a-induced expressions of antiapoptotic proteins such as cIAP1,
cIAP2, TRAF1, Bcl2 and FLIP, all of which are known to be regulated
by NF-kB. Furthermore, ﬂow cytometric analysis with Annexin V
staining indicated that ISOA potentiated TNF-a-induced apoptosis
signiﬁcantly via activation of caspase-8. TNF-a binding to its re-
ceptor induces not only antiapoptotic effects through the regula-
tion of activation NF-kB-dependent genes for cell-survival but also
apoptotic effects via activation of caspases (31, 32). However, TNF-
a-induced apoptosis plays only minor role due to antiapoptotic
effects of NF-kB activation (33).
NF-kB also controls the genes expression for cell proliferation
and tumor cell invasion (11). Our results showed that ISOA sup-
presses not only the expression of COX-2, which is known major
mediator of cell proliferation and survival but also the expression of
ICAM-1, which is known to be major mediators of tumor cell in-
vasion (9). Furthermore, our results indicated that the expression of
VEGF, one of the major mediators of angiogenesis, is suppressed by
ISOA. The anti-inﬂammatory effects of ISOA have been also
conﬁrmed via investigation of several major inﬂammatory cyto-
kines, such as TNF-a, IL-8, and MCP1, which are regulated by NF-kB
and are also potent activators for NF-kB. These proinﬂammatory
cytokines have profound effects on the regulation of immune re-
actions, hematopoiesis and inﬂammation (34).
In summary, our results suggest that ISOA could exhibit anti-
proliferative, proapoptotic, anti-invasive, antiangiogenic, and anti-
inﬂammatory effects through the suppression of NF-kB activation
and NF-kB-regulated gene products. Our results imply that ISOA
could be an interesting lead compound for the modulation of in-
ﬂammatory diseases as well as certain cancers in which inhibition
of NF-kB-activity may be desirable.Conﬂicts interest
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